Glenmark Pharmaceuticals (GLENMARK) — Board Meeting

📢 Key Event
48th AGM held on September 11, 2026, approved FY2025-26 financials and declared dividend

🔄 What Changed
Approved audited standalone and consolidated financial statements for FY2025-26

💡 Investor Takeaway
Shareholders approved key financials and dividend, signaling confidence in company performance and commitment to shareholder returns.

Glenmark Pharmaceuticals held its 48th AGM on September 11, 2026 via video conferencing, where shareholders approved the audited standalone and consolidated financial statements for FY2025-26, declared a dividend of Rs. 2.50 per share, reappointed Mrs. Blanche Saldanha as a Non-Executive Director, and ratified the Cost Auditor's remuneration for FY2026-27. The meeting concluded at 3:51 p.m. after a 30-minute e-voting window, with results filed in XBRL and available on the company website.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLENMARK ✨ Ask AI About This

About Glenmark Pharmaceuticals Ltd (GLENMARK)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹68,205.11 Cr P/E: 37.9 ROE: 20.3% ROCE: 24.8% Div Yield: 0.10%

View full GLENMARK stock details →

📡 Get AI alerts when GLENMARK files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLENMARK — Free

💡 Ask AI about this filing

"What was the exact dividend payout ratio based on FY2025-26 earnings?" "How does the reappointment of Mrs. Saldanha impact board composition and governance?" "What were the total voting turnout percentages for ordinary and special resolutions?"

Ask AI Free →

📊 More GLENMARK filings

See all GLENMARK filings →

🔥 Also filed on 11 September 2026

MPHASIS Mphasis Ltd Announcement ADANIPORTS Adani Ports & Special Economic Zone Ltd Announcement 517170 Edvenswa Enterprises Ltd Announcement SIGMAADV Sigma Advanced System Ltd Announcement MONEYBOXX Moneyboxx Finance Ltd Insider Trading 532336 Baron Infotech Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLENMARK files new disclosures

Track GLENMARK filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLENMARK — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd